These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2303532

  • 1. Model for drug uptake by brain tumors: effects of osmotic treatment and of diffusion in brain.
    Robinson PJ, Rapoport SI.
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):153-61. PubMed ID: 2303532
    [Abstract] [Full Text] [Related]

  • 2. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT, Snodgrass P, Dean RL, Kordower JH, Emerich DF.
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [Abstract] [Full Text] [Related]

  • 3. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
    Erdlenbruch B, Jendrossek V, Kugler W, Eibl H, Lakomek M.
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
    [Abstract] [Full Text] [Related]

  • 4. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
    Hiesiger EM, Voorhies RM, Basler GA, Lipschutz LE, Posner JB, Shapiro WR.
    Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
    [Abstract] [Full Text] [Related]

  • 5. The effect of hyperosmotic blood-brain barrier disruption on blood-to-tissue transport in ENU-induced gliomas.
    Warnke PC, Blasberg RG, Groothuis DR.
    Ann Neurol; 1987 Sep; 22(3):300-5. PubMed ID: 3118762
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE.
    Cancer Res; 1988 Feb 01; 48(3):694-701. PubMed ID: 3335031
    [Abstract] [Full Text] [Related]

  • 7. The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas.
    Nakagawa H, Groothuis D, Blasberg RG.
    Neurology; 1984 Dec 01; 34(12):1571-81. PubMed ID: 6504329
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
    Côté J, Savard M, Bovenzi V, Dubuc C, Tremblay L, Tsanaclis AM, Fortin D, Lepage M, Gobeil F.
    Neuropeptides; 2010 Apr 01; 44(2):177-85. PubMed ID: 20080302
    [Abstract] [Full Text] [Related]

  • 12. Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors.
    Elliott PJ, Hayward NJ, Dean RL, Blunt DG, Bartus RT.
    Cancer Res; 1996 Sep 01; 56(17):3998-4005. PubMed ID: 8752170
    [Abstract] [Full Text] [Related]

  • 13. Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions.
    Uehara H, Miyagawa T, Tjuvajev J, Joshi R, Beattie B, Oku T, Finn R, Blasberg R.
    J Cereb Blood Flow Metab; 1997 Nov 01; 17(11):1239-53. PubMed ID: 9390656
    [Abstract] [Full Text] [Related]

  • 14. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma.
    Groothuis DR, Lippitz BE, Fekete I, Schlageter KE, Molnar P, Colvin OM, Roe CR, Bigner DD, Friedman HS.
    Cancer Res; 1992 Oct 15; 52(20):5590-6. PubMed ID: 1394182
    [Abstract] [Full Text] [Related]

  • 15. [Regional blood flow of experimental brain tumors with special reference to effects of chemotherapy and radiotherapy].
    Nagashima T, Matsutani M, Tamura A, Orii H.
    No To Shinkei; 1985 Mar 15; 37(3):287-94. PubMed ID: 3860212
    [Abstract] [Full Text] [Related]

  • 16. Regional measurements of blood-to-tissue transport in experimental RG-2 rat gliomas.
    Groothuis DR, Fischer JM, Pasternak JF, Blasberg RG, Vick NA, Bigner DD.
    Cancer Res; 1983 Jul 15; 43(7):3368-73. PubMed ID: 6850641
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
    Kemper EM, Boogerd W, Thuis I, Beijnen JH, van Tellingen O.
    Cancer Treat Rev; 2004 Aug 15; 30(5):415-23. PubMed ID: 15245774
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.
    Elliott PJ, Hayward NJ, Huff MR, Nagle TL, Black KL, Bartus RT.
    Exp Neurol; 1996 Oct 15; 141(2):214-24. PubMed ID: 8812155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.